Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionLegacy Bridge, LLC
Latest Disclosed Ownership292 shares
Latest Disclosed Value $ 44,603
Legacy Bridge, LLC ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Legacy Bridge, LLC filed a 13F-HR form disclosing ownership of 292 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $44,603 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 292 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $41,949 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 45 10.00 0.0170
2026-01-23 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 40 8.11 0.0163
2025-11-12 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 37 5.71 0.0156
2025-08-06 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 35 9.38 0.0168
2025-05-08 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 33 14.29 0.0182
2025-01-22 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 28 -15.15 0.0148
2024-11-07 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 34 6.45 0.0181
2024-08-06 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 31 10.71 0.0183
2024-04-25 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 28 -3.45 0.0165
2024-01-17 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 29 0.00 0.0191
2023-10-11 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 30 0.00 0.0212
2023-07-11 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 29 11.54 0.0197
2023-04-24 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 27 0.00 0.0187
2023-01-11 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 26 18.18 0.0188
2022-11-02 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 22 -12.00 0.0175
2022-07-21 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 25 -3.85 0.0184
2022-04-28 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 292 0 0.00 26 0.00 0.0152
2022-01-18 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 292 -47 -13.86 26 -7.14 0.0135
2021-10-26 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 339 0 0.00 28 -9.68 0.0161
2021-08-03 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 339 -128 -27.41 31 -22.50 0.0175
2021-04-29 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 467 -47 -9.14 40 -18.37 0.0259
2021-02-02 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 514 0 0.00 49 8.89 0.0355
2020-10-19 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 514 -46 -8.21 45 -8.16 0.0411
2020-08-04 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 560 -252 -31.03 49 -26.87 0.0539
2020-05-01 2020-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 812 46 6.01 67 -8.22 0.0844
2020-04-09 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 812 46 67 84,984.3984
2020-02-04 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 766 -654 -46.06 73 -40.65 0.0606
2019-10-15 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,420 -424 -22.99 123 -26.79 0.1174
2019-07-11 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,844 0 0.00 168 -5.08 0.1620
2019-04-26 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,844 128 7.46 177 20.41 0.1825
2019-01-25 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,716 1,716 147 0.1819
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.